semaglutide novo nordisk patent New Delhi, March 19, 2026 – On Friday, the key on semaglutide—the active molecule in Nordisk's blockbuster drugs Ozempic and Wegovy—expired in India, marking a pivotal shift in the country's Ozempic's patent problem: how Novo
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12






















:max_bytes(150000):strip_icc()/TAL-tobacco-bay-beach-bermuda-BESTBEACH0326-f849910bb2f743babcb209e59a25cd94.jpg)